Patented biomarker for cardiac injury. 

Patented biomarker for cardiac injury. 

Comparing combined testing of cMyBP-C and hs-cTnT with other algorithms for rapid rule-out of acute myocardial infarction in suspected acute coronary syndrome patients

Incorporating cMyBP-C and hs-cTnT – effectively rules out AMI, showing non-inferiority to hs-cTnT-only-based rapid rule-out algorithms and offers a promising alternative, potentially enhancing clinical decision-making in emergency settings.

cMyC (Cardiac Myosin-binding protein C)
cMyC (Cardiac Myosin-binding protein C)